Company Filing History:
Years Active: 2007
Title: Shuntai Wang: Innovator in Transmembrane Receptor Agonists
Introduction
Shuntai Wang is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biochemistry, particularly in the area of transmembrane receptor agonists. His innovative work has led to the development of methods that enhance our understanding of receptor signaling.
Latest Patents
Shuntai Wang holds a patent titled "Methods of identifying reduced internalization transmembrane receptor agonists." This patent describes methods for identifying a transmembrane receptor (TMR) agonist and the compounds identified by this method. The TMR agonist (TMRA) is capable of activating TMR signaling while exhibiting reduced TMR internalization compared to a control compound. This innovation has the potential to advance therapeutic strategies in various medical applications.
Career Highlights
Shuntai Wang is currently employed at Molecular Devices Corporation, where he continues to push the boundaries of scientific research. His work at the company focuses on developing technologies that facilitate advancements in life sciences and drug discovery.
Collaborations
Shuntai Wang has collaborated with esteemed colleagues, including Carson R. Loomis and Robert H. Oakley. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Shuntai Wang's contributions to the field of transmembrane receptor agonists exemplify the impact of innovative research in biochemistry. His patent and ongoing work at Molecular Devices Corporation highlight his commitment to advancing scientific knowledge and technology.